Glycotest™ Expands Patent Portfolio with Chinese Patent
Glycotest™ Announces Grant of Japanese Patent
Glycotest™ Intellectual Property Portfolio Expanded by United Sates, European and Australian Patents
Glycotest Innovator Joins the Medical University of South Carolina as the New SmartState Endowed Chair of Proteomic Biomarkers
Glycotest Intellectual Property Portfolio Strengthened by Grant of Japanese Patent
Dr. Timothy Block, President, Baruch S. Blumberg Institute and the Hepatitis B Foundation, in a video on the Glycotest Technology
Lawrence Cohen, CEO of Glycotest, presented at Net Scientific’s June 2016 Capital Markets Day.
Lawrence Cohen, CEO of Glycotest, will be presenting the company at the New York Venture Summit on July 21, 2016.
NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D.